NOVASCAN NEUROIMAGING CLINICS Trademark
Trademark Overview
On Monday, October 27, 2025, a trademark application was filed for NOVASCAN NEUROIMAGING CLINICS with the United States Patent and Trademark Office. The USPTO has given the NOVASCAN NEUROIMAGING CLINICS trademark a serial number of 99464729. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, March 23, 2026. This trademark is owned by Algernon Pharmaceuticals Inc.. The NOVASCAN NEUROIMAGING CLINICS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Medical clinics featuring brain-specific Positron Emission Tomography (PET) scanner systems for the head and neck focused on the early-stage detection, diagnosis, and treatment of Alzheimer's Disease, and additional applications including early-stage detection, diagnosis, and treatment of other forms of dementia, epilepsy, neuro-oncology, and movement disorders
General Information
| Serial Number | 99464729 |
| Word Mark | NOVASCAN NEUROIMAGING CLINICS |
| Filing Date | Monday, October 27, 2025 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Monday, March 23, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Pseudo Mark | NOVA SCAN NEUROIMAGING CLINICS |
| NOT AVAILABLE | "NEUROIMAGING CLINICS" |
| Indication of Colors claimed | The color(s) blue, purple, green, pink, grey, and black is/are claimed as a feature of the mark. |
| Description of Mark | The mark consists of a design of five blue, purple, green, pink and grey overlapping circles of varying sizes and below this are five smaller circles shown in blue, purple, green, pink, and gray. Both groups of circles appear to the left of the word "NOVASCAN" with "NOVA" in black font and "SCAN" in grey font, the word "NOVASCAN" appearing over the words "NEUROIMAGING CLINICS" in black font. |
| Goods and Services | Medical clinics featuring brain-specific Positron Emission Tomography (PET) scanner systems for the head and neck focused on the early-stage detection, diagnosis, and treatment of Alzheimer's Disease, and additional applications including early-stage detection, diagnosis, and treatment of other forms of dementia, epilepsy, neuro-oncology, and movement disorders |
Classification Information
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 27, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Algernon Pharmaceuticals Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Vancouver, BC V5Z4C2
CA |
Trademark Events
| Event Date | Event Description |
| Monday, October 27, 2025 | NEW APPLICATION ENTERED |
| Monday, October 27, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 9, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 9, 2026 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, March 12, 2026 | ASSIGNED TO EXAMINER |
| Monday, March 23, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, March 23, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Monday, March 23, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, March 23, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 23, 2026 | SUSPENSION LETTER WRITTEN |
| Monday, March 23, 2026 | LETTER OF SUSPENSION E-MAILED |
| Monday, March 23, 2026 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
